Previous 10 | Next 10 |
Gainers: Houston American Energy HUSA +157%. Imperial Petroleum IMPP +95%. Indonesia Energy Corporation INDO +74%. Camber Energy (NYSE:CEI) +49%. Nine Energy Service NINE +42%. Sunworks (NASDAQ:SUNW) +31%. Bed Bath & Beyond BBBY +28%. Eqonex EQOS +28%. Marine...
RESEARCH TRIANGLE PARK, N.C., March 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today published new CNS (Central Nervous System) therapeutic data validating the growing trend toward decentralization as two-thirds ...
RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced its Operating System has earned ISO 27001 certification for cybersecurity management as well as the ISO 27701:2019 priv...
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Cowen 42 nd Annual Health Care Conference. Science 37 ...
RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ bolstered its centralized network of community providers by six times during the past year, contracting with more than 800 healthcare o...
RESEARCH TRIANGLE PARK, N.C. and CHICAGO, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, and physIQ Inc, a leader in digital medicine, today announced a collaboration to help research sponsors use remote biosens...
RESEARCH TRIANGLE PARK, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO) and Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating Sys...
LOS ANGELES, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Science 37, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System, today announced it has added capability to meet regulatory requirements and deploy its full-stack, end-to-end technology platform into China and Russia—further e...
LOS ANGELES, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37”), pioneer of decentralization and Operating System for today’s more agile clinical trials™, has published new data suggesting that the clinical research industry...
Science 37 (NASDAQ:SNCE): Q3 GAAP EPS of -$3.23 misses by $1.30. Revenue of $14.24M (+116.4% Y/Y) beats by $1.15M. Press Release For further details see: Science 37 EPS misses by $1.30, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
Science 37 Holdings Inc. Company Name:
SNCE Stock Symbol:
NASDAQ Market:
Science 37 Holdings Inc. Website:
MORRISVILLE, N.C., July 18, 2024 (GLOBE NEWSWIRE) -- Science 37 , a leader in enhancing patient access to clinical trials, disclosed the final figures resulting from its partnership with a biopharmaceutical company focused on infectious disease prevention research. Science 37 contributed ...
RESEARCH TRIANGLE PARK, N.C., June 27, 2024 (GLOBE NEWSWIRE) -- Science 37 , a leader in enhancing patient access to clinical trials, has been added to over 20 studies that were lagging in recruitment, helping them to trend back towards their projected targets. Leveraging its proprietary ...
RESEARCH TRIANGLE PARK, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Science 37, Inc., please note that the first sentence of the second paragraph has been revised. The corrected release follows: Science 37 Holdings, Inc. , a lea...